Cooperative Genomic Lesions in HRAS-Mutant Cancers Predict Resistance to Farnesyltransferase Inhibitors.

MLA

Nigam, Aradhya, et al. “Cooperative Genomic Lesions in HRAS-Mutant Cancers Predict Resistance to Farnesyltransferase Inhibitors.” Research Square, July 2023. EBSCOhost, https://doi.org/10.21203/rs.3.rs-3154719/v1.

APA

Nigam, A., Krishnamoorthy, G., Chatila, W., Berman, K., Saqcena, M., Walch, H., Ho, A., Schultz, N., Fagin, J., & Untch, B. (2023). Cooperative Genomic Lesions in HRAS-Mutant Cancers Predict Resistance to Farnesyltransferase Inhibitors. Research Square. https://doi.org/10.21203/rs.3.rs-3154719/v1

Chicago

Nigam, Aradhya, Gnana Krishnamoorthy, Walid Chatila, Katherine Berman, Mahesh Saqcena, Henry Walch, Alan Ho, Nikolaus Schultz, James Fagin, and Brian Untch. 2023. “Cooperative Genomic Lesions in HRAS-Mutant Cancers Predict Resistance to Farnesyltransferase Inhibitors.” Research Square, July. doi:10.21203/rs.3.rs-3154719/v1.